SRS Capital Advisors »

Lb Pharmaceuticals shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Lb Pharmaceuticals (LBRX) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $356 11 32.45

More positions owned by SRS Capital Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Comfort Systems USA (FIX)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard Index Fds Value Etf (VTV)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for SRS Capital Advisors

Top funds holding Lb Pharmaceuticals

Deep Track Capital
BlackRock
RA Capital Management
Trails Edge Capital Partners
Commodore Capital
Jpmorgan Chase & Co
TCG Crossover Management
Caligan Partners
Spruce Street Capital
Nantahala Capital Management
Vanguard Capital Management
Balyasny Asset Management
Alyeska Investment Group
Vivo Capital
Nan Fung Group Holdings

View all funds holding Lb Pharmaceuticals